Gene · 9965
Papers4,178
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 4,178
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Selection and Optimization of a High-Affinity FGFR4 Aptamer that Blocks FGF19-FGFR4 Signaling. | Anal Chem | 2026 | 42159546 | PubTator, text mining | PubMed |
| Effect of different sources of saturated and polyunsaturated fatty acids on postprandial inflammation: A double-blind randomized crossover trial. | Clin Nutr ESPEN | 2026 | 42128091 | PubTator, text mining | PubMed |
| Dissecting non-small cell lung cancer (NSCLC) with blood proteomics-from surgical to immunotherapeutic responses. | NPJ Precis Oncol | 2026 | 42120924 | PubTator, text mining | PubMed |
| Genetic Evidence Linking Inflammatory Cytokines and Blood Metabolites to Heart Failure Risk. | Cardiovasc Ther | 2026 | 42112763 | PubTator, text mining | PubMed |
| Prevalence of Bile Acid Diarrhea and Effect of Budesonide on the Bile Acid Homeostasis in Flare of Microscopic Colitis. | Gastro Hep Adv | 2026 | 42109273 | PubTator, text mining | PubMed |
| Traditional Chinese Medicine Modulation of the Gut-Liver Axis: From Barrier Disruption to Inflammasome Activation in MASLD/MASH. | J Vis Exp | 2026 | 42081375 | PubTator, text mining | PubMed |
| Activation of Brown Adipocytes by Farnesoid X Receptor Agonist, Obeticholic Acid-A Potential Novel Therapeutic Avenue in the Management of Obesity. | J Clin Med | 2026 | 42074889 | PubTator, text mining | PubMed |
| Glucagon-Like Peptide-1 Receptor Agonists for Bile Acid Diarrhea: Emerging Evidence and Clinical Implications. | Cureus | 2026 | 42037908 | PubTator, text mining | PubMed |
| The FGF-FGFR axis as an immune-metabolic rheostat in gastrointestinal inflammation and cancer. | Front Immunol | 2026 | 41972170 | PubTator, text mining | PubMed |
| Short-term response to alectinib and rapid progression in a lung squamous cell carcinoma patient harboring an EML4-ALK fusion: a case report. | Transl Cancer Res | 2026 | 41969449 | PubTator, text mining | PubMed |
| Age-associated regulation of chondrocyte hypertrophy in osteoarthritis: Mechanisms, therapeutic implications, and cartilage fate reprogramming. | Ageing Res Rev | 2026 | 41967814 | PubTator, text mining | PubMed |
| Acute responses of inflammatory markers, glucose, and myoglobin in blood following neuromuscular electrical stimulation. | Eur J Appl Physiol | 2026 | 41925840 | PubTator, text mining | PubMed |
| Increased intestinal Lactobacillus abundance in post-pancreatectomy steatotic liver disease is associated with altered bile acid metabolism and FXR-FGF19 pathway suppression. | Gut Microbes Rep | 2026 | 41907519 | PubTator, text mining | PubMed |
| Integrative Multi-Analysis Identifies METTL3-Regulated FGF19 and H6PD as Candidate Targets in Diabetic Cognitive Impairment. | Biomolecules | 2026 | 41897403 | PubTator, text mining | PubMed |
| Serum Metabolomic Signatures Indicate Oxidative Membrane Lipid Remodeling in β-Thalassemia. | Metabolites | 2026 | 41893322 | PubTator, text mining | PubMed |
| Translating Fibrosis to Malignancy: Biomarkers and Therapeutic Opportunities in Liver Fibrosis and Hepatocellular Carcinoma. | Med Sci (Basel) | 2026 | 41892825 | PubTator, text mining | PubMed |
| Upregulated beta-defensin-1 in murine and human biliary atresia associates with human native liver survival. | Sci Rep | 2026 | 41888359 | PubTator, text mining | PubMed |
| Molecular and Clinical Profile of a RET-Rearranged Colorectal Cancer With Prolonged Response to Platinum Therapy and Subsequent Targeted Treatment With Selpercatinib. | JCO Precis Oncol | 2026 | 41881065 | PubTator, text mining | PubMed |
| Disordered Bile Acid Metabolism in Alcohol-Related Hepatitis. | Aliment Pharmacol Ther | 2026 | 41870486 | PubTator, text mining | PubMed |
| Follow-up of jaundice-free biliary atresia survivors using M2BPGi and APRI in a local hospital. | World J Pediatr Surg | 2026 | 41853388 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9965/papers?page=3